A global research priority agenda to advance public health responses to fatty liver diseaseRamón Bataller, Thomas Berg, Paul Brennan et al.|Journal of Hepatology|2023Cited by 132
A global action agenda for turning the tide on fatty liver diseaseJeffrey V. Lazarus, Henry E. Mark, Alina M. Allen et al.|Hepatology|2023Cited by 90
Opportunities and challenges following approval of resmetirom for MASH liver diseaseJeffrey V. Lazarus, Paul Brennan, Dana Ivancovsky‐Wajcman et al.|Nature Medicine|2024Cited by 57
A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver diseaseDana Ivancovsky‐Wajcman, Jeffrey V. Lazarus, Christopher J. Byrne et al.|Hepatology|2024Cited by 29